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Reply
We appreciate our colleagues’ interest in our study. We rather
enjoy the fact that it has raised their collective ire and appreciate
the Journal of Vascular Surgery forum to debunk the myth that
medical therapy will control carotid atherosclerosis. Ours was a
natural history study of patients with asymptomatic moderate
(50%-69%) carotid stenosis who we and everyone else treat
with medical therapy. At no point in the article did we suggest
or recommend that patients with asymptomatic moderate ca-
rotid stenosis undergo any intervention. The authors suggest
that subgroups of patients who would beneﬁt from optimal
medical therapy (OMT) plus surgery for asymptomatic stenosis
have not been identiﬁed. This is, of course, refuted by level 1
evidence,1 and the management strategies embodied in ﬁve
different international guidelines (including that of the Society
for Vascular Surgery [SVS]) published since 2010. Further-
more, the Asymptomatic Carotid Stenosis and Risk of Stroke
(ACSRS) studies, which our correspondents quote and contrib-
uted to, have shown a consistent correlation with the degree of
stenosis and stroke risk.2,3 In ACSRS, patients with an asymp-
tomatic stenosis of a degree wherein surgery would be recom-
mended by current SVS guidelines had a 10% event rate(transient ischemic attack and stroke in approximately a 50/
50 distribution) at just 3 years of follow-up. Ironically, the
most recent ACSRS report further emphasizes the signiﬁcant
impact of lesion progression (the focus of our study) and ﬁnal
degree of stenosis in the prediction of stroke risk.4 In addition,
the 10-year data from the ACST trial showed a signiﬁcant
beneﬁt of carotid endarterectomy over medical therapy despite
an 80% statin use in the later years of the trial.1
The authors began their letter with the statement that “ﬂawed
conclusions may follow from studies with substantial limitations”;
we agree. A good example is the meta-analysis published by Dr
Abbott in 2009, concluding that medical treatment alone is best
for prevention of stroke in patients with asymptomatic severe ca-
rotid stenosis.5 The major ﬂaw of this study was that it did not
differentiate between patients with moderate stenosis (those with
an extremely low stroke risk) and severe stenosis (those who are
at higher risk of stroke with medical therapy alone). The studies
that drive the meta-analysis conclusions included disproportionate
numbers of patients with moderate stenosis. For example, the Ox-
ford Vascular Study reported an annual stroke rate of 0.34% in
medically treated patients with asymptomatic carotid stenosis.6
However, only 32 of the 1152 (2.8%) patients had a degree of ca-
rotid stenosis for which intervention would have been recommen-
ded, and 3 of these (10%) had a stroke.6
It is easy to ﬁnd fault with attempts to deﬁne OMT in medically
treated patients, and we acknowledge the same in our report. Within
the limitations of retrospective review, our study does represent
“real-world” practice in a health system in which, as shown, 87%
of patients in the cohort were taking aspirin and statins. This study
was borne of the rather common observation of lesion progression
in patients receiving adequate, even “optimal”medical therapy. Our
study, in fact, joins many others documenting (1) substantial rates of
carotid lesion progression despite statin therapy and (2) the
ominous implications of lesion progression.4,7-9
The ultimate message of our study was that patients with
asymptomatic moderate carotid stenosis require serial follow-up
imaging despite OMT because a large percentage will progress
to a severe lesion that would ultimately put them at increased
risk of stroke. Our correspondents are understandably uncomfort-
able that data are emerging that refute their “revisionist history”
that medical therapy will control asymptomatic carotid stenosis.
Mark Frederick Conrad, MD, MMSc
Richard P. Cambria, MD
Massachusetts General Hospital
Boston, Mass
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